Magnesium L-threonate (Magtein)

Magnesium L-threonate (brand Magtein) is a magnesium form marketed to slow aging and support longevity, with manufacturers promising brain protection and a longer healthy life. No convincing data show the supplement slows aging or extends lifespan; this use rests on lab work and a few small studies rather than a solid evidence base in people. Healthy aging actually responds to well-established measures: controlling blood pressure, glucose and lipids, staying physically active, not smoking, sleeping well and eating a balanced diet. Do not take magnesium L-threonate in place of these measures, since swapping a proven approach for a supplement with no demonstrated benefit leaves real risks untreated.

Magnesium L-threonate is advertised as the «best magnesium form for sleep». No quality RCTs of threonate specifically in insomnia patients exist. The pooled magnesium literature (Mah 2021 systematic review, mostly oxide and citrate) reported a weak effect on sleep latency and quality in older adults; the signal is inconclusive and does not single out the threonate form. AASM 2023 and SEPAR sleep guidance set cognitive-behavioural therapy (CBT-I) as the first line for insomnia, not magnesium. For chronic insomnia, discuss CBT-I with a general practitioner or sleep specialist and, when indicated, short pharmacological courses with regular review. Plain magnesium glycinate at bedtime offers a comparable effect to Magtein at 4–6 times lower cost.

ICD-10: G47.0 · ICD-11: 7A00

Magnesium L-threonate is marketed as «magnesium for the brain», citing preclinical data on raised CSF magnesium and synapse density in rodents. The pivotal human study is Liu 2016: 44 patients aged 50–70 with mild cognitive impairment, open control arm, Magtein-sponsored, 12 weeks, with improvement on a composite cognitive test. The small sample size, conflict of interest and absence of independent replication are serious limitations. NIH ODS maintains a general magnesium monograph but has not issued specific guidance on the L-threonate form. EFSA 2010 approved a generic magnesium health claim for normal nervous function – it applies to every form of magnesium (citrate, glycinate, oxide, threonate), not only Magtein. No head-to-head RCTs of glycinate vs threonate in humans exist. For memory and concentration the evidence supports physical activity, sleep hygiene, BP and glucose control, not an expensive magnesium form.